These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38839520)

  • 1. Ovine papillomavirus type 3 virus-like particle-based tools for diagnosis and detection of infection.
    Cacciotto C; Dore GM; Cubeddu T; Burrai GP; Anfossi AG; Antuofermo E; Varoni MV; Demontis MP; Zobba R; Pittau M; Müller M; Alberti A
    Vaccine; 2024 Sep; 42(22):126033. PubMed ID: 38839520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic profiles and cytokeratin 13 as a potential biomarker of Ovis aries papillomavirus 3-positive and negative cutaneous squamous cell carcinomas.
    Vitiello V; Burrai GP; Pisanu S; Cacciotto C; Addis MF; Alberti A; Antuofermo E; Cubeddu T; Pirino S
    Res Vet Sci; 2021 Jan; 134():112-119. PubMed ID: 33360571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovis aries Papillomavirus 3 in Ovine Cutaneous Squamous Cell Carcinoma.
    Vitiello V; Burrai GP; Agus M; Anfossi AG; Alberti A; Antuofermo E; Rocca S; Cubeddu T; Pirino S
    Vet Pathol; 2017 Sep; 54(5):775-782. PubMed ID: 28494708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of immunodiagnostic tools for in situ investigation of Ovis aries papillomavirus 3 (OaPV3).
    Cacciotto C; Dore GM; Anfossi AG; Tore G; Varoni MV; Demontis MP; Antuofermo E; Pittau M; Alberti A
    Vet Res Commun; 2023 Jun; 47(2):641-649. PubMed ID: 36331789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovis aries Papillomavirus 3: a prototype of a novel genus in the family Papillomaviridae associated with ovine squamous cell carcinoma.
    Alberti A; Pirino S; Pintore F; Addis MF; Chessa B; Cacciotto C; Cubeddu T; Anfossi A; Benenati G; Coradduzza E; Lecis R; Antuofermo E; Carcangiu L; Pittau M
    Virology; 2010 Nov; 407(2):352-9. PubMed ID: 20863546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming properties of ovine papillomaviruses E6 and E7 oncogenes.
    Tore G; Dore GM; Cacciotto C; Accardi R; Anfossi AG; Bogliolo L; Pittau M; Pirino S; Cubeddu T; Tommasino M; Alberti A
    Vet Microbiol; 2019 Mar; 230():14-22. PubMed ID: 30827380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of a novel cross-species transmission by ovine papillomaviruses.
    De Falco F; Cutarelli A; Cuccaro B; Catoi C; De Carlo E; Roperto S
    Transbound Emerg Dis; 2022 Nov; 69(6):3850-3857. PubMed ID: 36335589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Epidemiology of Ovine Papillomavirus Infections Among Sheep in Southern Italy.
    De Falco F; Cutarelli A; D'Alessio N; Cerino P; Catoi C; Roperto S
    Front Vet Sci; 2021; 8():790392. PubMed ID: 34881323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bottlenose dolphin (Tursiops truncatus) papillomaviruses: vaccine antigen candidates and screening test development.
    Rehtanz M; Bossart GD; Doescher B; Rector A; Van Ranst M; Fair PA; Jenson AB; Ghim SJ
    Vet Microbiol; 2009 Jan; 133(1-2):43-53. PubMed ID: 18676105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of recombinant virus-like particles from human papillomavirus types 6 and 11, and study of serological reactivities between HPV 6, 11, 16 and 45 by ELISA: implications for papillomavirus prevention and detection.
    Touzé A; Dupuy C; Mahé D; Sizaret PY; Coursaget P
    FEMS Microbiol Lett; 1998 Mar; 160(1):111-8. PubMed ID: 9495021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of a competitive ELISA using a monoclonal antibody for antibody detection after goose parvovirus virus-like particles (VLPs) and vaccine immunization in goose sera.
    Wang Q; Ju H; Li Y; Jing Z; Guo L; Zhao Y; Ma B; Gao M; Zhang W; Wang J
    J Virol Methods; 2014 Dec; 209():69-75. PubMed ID: 25196452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-based ELISA reduces background reactivity in virus-like particle-based papillomavirus serology.
    Wang X; Sapp M; Christensen ND; Dillner J
    J Gen Virol; 2005 Jan; 86(Pt 1):65-73. PubMed ID: 15604432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of virus-neutralizing antibodies and T cell responses by dengue virus type 1 virus-like particles prepared from Pichia pastoris.
    Tang YX; Jiang LF; Zhou JM; Yin Y; Yang XM; Liu WQ; Fang DY
    Chin Med J (Engl); 2012 Jun; 125(11):1986-92. PubMed ID: 22884066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillomavirus virus like particle-based therapeutic vaccine against human papillomavirus infection related diseases: immunological problems and future directions.
    Chen J; Ni G; Liu XS
    Cell Immunol; 2011; 269(1):5-9. PubMed ID: 21477796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillomavirus-like particle vaccines.
    Schiller JT; Lowy DR
    J Natl Cancer Inst Monogr; 2001; (28):50-4. PubMed ID: 11158207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective vaccination against papillomavirus-induced skin tumors under immunocompetent and immunosuppressive conditions: a preclinical study using a natural outbred animal model.
    Vinzón SE; Braspenning-Wesch I; Müller M; Geissler EK; Nindl I; Gröne HJ; Schäfer K; Rösl F
    PLoS Pathog; 2014 Feb; 10(2):e1003924. PubMed ID: 24586150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection.
    Monroy-García A; Gómez-Lim MA; Weiss-Steider B; la Rosa GP; Hernández-Montes J; Pérez-Saldaña K; Tapia-Guerrero YS; Toledo-Guzmán ME; Santiago-Osorio E; Sanchez-Peña HI; Mora-García Mde L
    Virol J; 2011 Feb; 8():59. PubMed ID: 21306638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies.
    Nainys J; Lasickiene R; Petraityte-Burneikiene R; Dabrisius J; Lelesius R; Sereika V; Zvirbliene A; Sasnauskas K; Gedvilaite A
    BMC Biotechnol; 2014 Dec; 14():100. PubMed ID: 25487652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillomavirus virus-like particles as anticancer vaccines.
    Da Silva DM; Velders MP; Rudolf MP; Schiller JT; Kast WM
    Curr Opin Mol Ther; 1999 Feb; 1(1):82-8. PubMed ID: 11249689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.